Iris Barshack

19.4k total citations · 1 hit paper
258 papers, 8.1k citations indexed

About

Iris Barshack is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Iris Barshack has authored 258 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Molecular Biology, 57 papers in Oncology and 53 papers in Cancer Research. Recurrent topics in Iris Barshack's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (19 papers) and Cell Adhesion Molecules Research (14 papers). Iris Barshack is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (19 papers) and Cell Adhesion Molecules Research (14 papers). Iris Barshack collaborates with scholars based in Israel, United States and United Kingdom. Iris Barshack's co-authors include Iris Goldberg, Camila Avivi, Juri Kopolovic, Sarah Ferber, Dror Harats, Aviv Shaish, Hofit Cohen, Avraham Karasik, Jacob George and Arnon Afek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Iris Barshack

249 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia

2000 585 citations Iris Barshack et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Barshack Israel	46	3.3k	1.8k	1.6k	1.6k	1.3k	258	8.1k
Yusuke Nakamura Japan	54	4.6k 1.4×	1.2k 0.7×	2.1k 1.4×	1.5k 1.0×	1.5k 1.2×	160	10.4k
George E. Sandusky United States	46	5.3k 1.6×	1.6k 0.9×	1.2k 0.8×	1.3k 0.8×	770 0.6×	201	9.6k
Hermann-Josef Gröne Germany	62	5.0k 1.5×	1.2k 0.7×	1.3k 0.8×	942 0.6×	2.7k 2.1×	170	11.9k
Luigi Maria Larocca Italy	54	3.5k 1.1×	1.3k 0.7×	3.3k 2.1×	1.6k 1.0×	1.1k 0.8×	338	10.4k
Achim Weber Switzerland	55	2.9k 0.9×	2.1k 1.2×	2.6k 1.7×	1.3k 0.8×	1.5k 1.2×	213	9.0k
Wolfgang Poller Germany	54	3.0k 0.9×	1.2k 0.7×	851 0.5×	908 0.6×	922 0.7×	171	9.5k
Paul H.A. Quax Netherlands	59	5.2k 1.6×	2.4k 1.4×	1.6k 1.0×	3.0k 1.9×	2.6k 2.0×	295	11.7k
Marc K. Halushka United States	56	4.4k 1.3×	1.7k 1.0×	1.8k 1.1×	2.2k 1.4×	796 0.6×	215	11.8k
Paul J. Higgins United States	45	4.0k 1.2×	835 0.5×	1.2k 0.7×	1.5k 1.0×	1.1k 0.9×	226	8.5k
Pieter Demetter Belgium	43	1.8k 0.5×	1.2k 0.7×	2.5k 1.6×	940 0.6×	1.1k 0.8×	199	6.4k

Countries citing papers authored by Iris Barshack

Since Specialization

Citations

This map shows the geographic impact of Iris Barshack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Barshack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Barshack more than expected).

Fields of papers citing papers by Iris Barshack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Barshack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Barshack. The network helps show where Iris Barshack may publish in the future.

Co-authorship network of co-authors of Iris Barshack

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Barshack. A scholar is included among the top collaborators of Iris Barshack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Barshack. Iris Barshack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monteran, Lea, Nour Ershaid, Ye’ela Scharff, et al.. (2024). Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity. Cancer Discovery. 14(7). 1252–1275. 17 indexed citations

Oiknine, Yaniv, et al.. (2023). Compressive hyperspectral microscopy for cancer detection. Journal of Biomedical Optics. 28(9). 96502–96502. 5 indexed citations

Vered, Marilena, Ronnie Shapira‐Frommer, Nethanel Asher, et al.. (2023). Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach. JNCI Journal of the National Cancer Institute. 116(4). 539–546. 11 indexed citations

Markovits, Ettai, Erez N. Baruch, Eldad D. Shulman, et al.. (2023). MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2. Cancer Immunology Research. 11(7). 909–924. 8 indexed citations

Kamari, Yehuda, Michal Kandel-Kfir, Iris Barshack, et al.. (2022). β-Carotene from the Alga Dunaliella bardawil Decreases Gene Expression of Adipose Tissue Macrophage Recruitment Markers and Plasma Lipid Concentrations in Mice Fed a High-Fat Diet. Marine Drugs. 20(7). 433–433. 8 indexed citations

Shani, Ophir, Tatiana Vorobyov, Lea Monteran, et al.. (2020). Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity. Cancer Research. 80(23). 5317–5329. 110 indexed citations

Kamer, Iris, Elizabeta Bab-Dinitz, Gili Perry, et al.. (2020). Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling. Molecular Cancer Research. 18(6). 926–937. 9 indexed citations

Vax, Einav, et al.. (2020). Inhibition of Ras GTPases prevents Collagen‐Induced Arthritis by Reducing the Generation of Pathogenic CD4⁺ T Cells and the Hyposialylation of Autoantibodies. ACR Open Rheumatology. 2(9). 512–524. 1 indexed citations

Ofek, Efrat, Jair Bar, Nadia Prisant, et al.. (2020). MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study. Journal of Clinical Pathology. 73(10). 636–641. 16 indexed citations

10.

Ben‐Hamo, Rotem, Alona Zilberberg, Helit Cohen, et al.. (2019). Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types. npj Precision Oncology. 3(1). 12–12. 27 indexed citations

11.

Almog, Tal, Gadi Shlomai, Iris Barshack, et al.. (2019). Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice. BMJ Open Diabetes Research & Care. 7(1). e000650–e000650. 20 indexed citations

12.

Shipony, Zohar, Masha Kolesnikov, Camila Avivi, et al.. (2019). Reduced CTL motility and activity in avascular tumor areas. Cancer Immunology Immunotherapy. 68(8). 1287–1301. 25 indexed citations

13.

Persi, Erez, Davide Prandi, Yuri I. Wolf, et al.. (2019). Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues. Proceedings of the National Academy of Sciences. 116(34). 16987–16996. 10 indexed citations

14.

Shaashua, Lee, Maytal Shabat-Simon, Rita Haldar, et al.. (2017). Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial. Clinical Cancer Research. 23(16). 4651–4661. 195 indexed citations

15.

Gibori, Hadas, Adva Krivitsky, Dikla Ben‐Shushan, et al.. (2017). Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nature Communications. 9(1). 16–16. 79 indexed citations

16.

Dadiani, Maya, Noa Bossel Ben‐Moshe, Shani Paluch–Shimon, et al.. (2016). Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer. Clinical Cancer Research. 22(14). 3651–3662. 7 indexed citations

17.

Ortenberg, Rona, Liat Hershkovitz, Sivan Sapoznik, et al.. (2012). Novel Immunotherapy for Malignant Melanoma with a Monoclonal Antibody That Blocks CEACAM1 Homophilic Interactions. Molecular Cancer Therapeutics. 11(6). 1300–1310. 59 indexed citations

18.

Abramovitz, Lilach, Tamar Rubinek, Hagai Ligumsky, et al.. (2011). KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer. Clinical Cancer Research. 17(13). 4254–4266. 107 indexed citations

19.

Peled, Michael, Aviv Shaish, Shoshana Greenberger, et al.. (2009). Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats. Clinical Cancer Research. 15(5). 1664–1673. 6 indexed citations

20.

Shiri‐Sverdlov, Ronit, Iris Barshack, Ruth Gershoni Baruch, et al.. (2000). Genetic Analyses of Male Breast Cancer in Israel. Genetic Testing. 4(3). 313–317. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact